Is losartan as effective as enalapril on posttransplant persistent proteinuria?

被引：6
作者：
Altiparmak, MR
Trablus, S
Apaydin, S
Basar, Ö
Sariyar, M
Serdengeçti, K
Erek, E
机构：
[1] Cerrahpasa Med Fac, Dept Nephrol, Istanbul, Turkey
[2] Cerrahpasa Med Fac, Dept Internal Med, Istanbul, Turkey
[3] Cerrahpasa Med Fac, Dept Surg, Istanbul, Turkey
来源：
TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 7-8期
关键词：
D O I：
10.1016/S0041-1345(01)02450-2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：3368 / 3369
页数：2
相关论文
共 7 条
[1]   Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy [J].
Campistol, JM ;
Iñigo, P ;
Jimenez, W ;
Lario, S ;
Clesca, PH ;
Oppenheimer, F ;
Rivera, F .
KIDNEY INTERNATIONAL, 1999, 56 (02) :714-719
[2]   Role of transforming growth factor-β1 in the progression of chronic allograft nephropathy [J].
Campistol, JM ;
Iñigo, P ;
Larios, S ;
Bescos, M ;
Oppenheimer, F .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 :114-116
[3]   Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients [J].
Del Castillo, D ;
Campistol, JM ;
Guirado, L ;
Capdevilla, L ;
Martínez, JG ;
Pereira, P ;
Bravo, J ;
Pérez, R .
KIDNEY INTERNATIONAL, 1998, 54 :S135-S139
[4]  
GANSEVOORT RT, 1994, J HYPERTENS, V12, pS37
[5]   Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation [J].
Holgado, R ;
Anaya, F ;
Del Castillo, D .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 :117-120
[6]  
KASISKE B, 2001, HDB KIDNEY TRANSPLAN, P182
[7]   Control of severe proteinuria with losartan after renal transplantation [J].
Navarro, JF ;
Macía, ML ;
García, J .
AMERICAN JOURNAL OF NEPHROLOGY, 1998, 18 (03) :261-262
1